Market Snapshot

BSE Sensex: 75237.99 -0.21%
BSE 500: 35236.5 -0.36%
BSE 200: 10986.48 -0.35%
BSE 100: 25051.12 -0.28%
BSE BANKEX: 60489.34 -0.77%
BSE IT: 26964.26 1.06%
Nifty 50: 23643.5 -0.19%
Nifty 500: 22531.15 -0.36%
Nifty 200: 13596.35 -0.36%
Nifty 100: 24572.15 -0.33%
Nifty Midcap 100: 60567.15 -0.45%
Nifty Small 100: 17882.6 -0.61%
Nifty IT: 27716.9 1.30%
Nifty PSU Bank: 8027.2 -1.80%

News:

Azad Engineering Q4 PAT climbs...
Atul Auto Q4 PAT surges 107% Y...
SAIL reports 43% surge in Q4 P...
Greenpanel Industries clocks P...
Shriram Asset Management Compa...

Astrazeneca Pharma India Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

15 May 2026 | 04:14 PM

8,468.50

116.50 (1.39%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

6.46%

Return (1Y)

Beaten Nifty 50 by 12.12%
More Volatile

1.88%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.07%
Not so consistent

6/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

10,691

7,552

News & Announcements

Astrazeneca Pharma India gets CDSCO approval for Acalabrutinib tablets
34 days ago

Astrazeneca Pharma India gets CDSCO approval for Acalabrutinib tablets

13 - Apr - 2026 12:00 | 34 days ago

Through this approval, Acalabrutinib tablets 100 mg in combination with venetoclax with or without obinutuzumab is indicated for the treatment of patients with previously untreated chronic lymphocytic leukaemia (CLL) /small lymphocytic lymphoma (SLL).
This regulatory clearance paves the way for the commercial launch and availability of Calquence in the Indian market.
AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines in four areas: Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Rare Diseases. It operates in over 100 countries.
The company?s standalone net profit declined 42.3% to Rs 31.55 crore despite 38.9% increase in net sales to Rs 615.57 crore in Q3 FY26 over Q3 FY25.
The counter advanced 1.45% to end at Rs 8,291.50 on Friday, 10 April 2026.
Astrazeneca Pharma India director resigns
58 days ago

Astrazeneca Pharma India director resigns

20 - Mar - 2026 12:00 | 58 days ago

Astrazeneca Pharma India announced that Jes?s Diaz-Ropero Esteso has resigned from the position of Non-Executive Director of AstraZeneca Pharma India and consequently from the Board Committee(s) on which he served, with immediate effect, due to a transition from current responsibilities.
Powered by Capital Market - Live News
Astrazeneca Pharma India appoints Director - Legal
67 days ago

Astrazeneca Pharma India appoints Director - Legal

11 - Mar - 2026 12:00 | 67 days ago

The board of Astrazeneca Pharma India has appointed Sandhya Tejaswini Amanna as Director - Legal, with effect from 18 March 2026.
Powered by Capital Market - Live News
Astrazeneca Pharma India standalone net profit rises 5.64% in the December 2025 quarter
94 days ago

Astrazeneca Pharma India standalone net profit rises 5.64% in the December 2025 quarter

12 - Feb - 2026 12:00 | 94 days ago

Net profit of Astrazeneca Pharma India rose 5.64% to Rs 32.59 crore in the quarter ended December 2025 as against Rs 30.85 crore during the previous quarter ended December 2024. Sales rose 38.90% to Rs 611.57 crore in the quarter ended December 2025 as against Rs 440.29 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 611.57 440.29 39

OPM % 7.33 17.49 -

PBDT 48.90 84.64 -42

PBT 45.06 75.57 -40

NP 32.59 30.85 6

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Astrazeneca Pharma India Ltd has increased by 4.23% since past 3 Months
FII shareholding in Astrazeneca Pharma India Ltd has decreased by -3.64% since past 1 Year
MF shareholding in Astrazeneca Pharma India Ltd has increased by 27.38% since past 1 Year
Astrazeneca Pharma India Ltd has the 2nd highest P/Bratio according to FY202503 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	611.57	440.29	39
OPM %	7.33	17.49	-
PBDT	48.90	84.64	-42
PBT	45.06	75.57	-40
NP	32.59	30.85	6

General Notifications

My Notifications

Research Notifications

Astrazeneca Pharma India Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

8,468.50 116.50 (1.39%)

News & Announcements

Price vs Volume

Stock Trivia

Astrazeneca Pharma India Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

8,468.50

116.50 (1.39%)